Podnos Yale 4
4 · Oncology Institute, Inc. · Filed Nov 21, 2024
Insider Transaction Report
Form 4
Podnos Yale
Chief Medical Officer
Transactions
- Disposition to Issuer
Common stock
2024-11-20$0.14/sh−1,709$232→ 74,261 total - Disposition to Issuer
Common stock
2024-11-20$0.14/sh−267$36→ 73,994 total - Disposition to Issuer
Common stock
2024-11-20$0.14/sh−1,026$140→ 72,968 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
- [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.135 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.